SOPHiA GENETICS officer plans sale of 774 shares

Rhea-AI Filing Summary

SOPHiA GENETICS SA (SOPH) received a notice that officer George Cardoza intends to sell 774 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services, with the securities originating from Restricted Stock Units granted by the issuer on September 18, 2026.

The notice also reports prior 10b5-1 sales during the past three months: 1,592 shares of common stock sold on July 6, 2026 for $8,419.45, and 774 shares sold on June 22, 2026 for $4,163.73.

Key Figures

Planned Rule 144 sale: 774 shares Recent 10b5-1 sale (shares): 1,592 shares Recent 10b5-1 sale value: $8,419.45 +3 more

6 metrics

Planned Rule 144 sale 774 shares Common stock to be sold by officer George Cardoza under Rule 144

Recent 10b5-1 sale (shares) 1,592 shares Common stock sold on July 6, 2026

Recent 10b5-1 sale value $8,419.45 Proceeds from sale of 1,592 shares on July 6, 2026

Earlier 10b5-1 sale (shares) 774 shares Common stock sold on June 22, 2026

Earlier 10b5-1 sale value $4,163.73 Proceeds from sale of 774 shares on June 22, 2026

RSU grant date September 18, 2026 Restricted Stock Units from which the planned 774-share sale arises

Key Terms

Rule 144, Restricted Stock Units, 10b5-1, Executive Financial Services

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 09/18/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for GEORGE CARDOZA"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for SOPH?

It discloses that officer George Cardoza plans to sell 774 shares of SOPHiA GENETICS SA common stock under Rule 144, with the shares coming from Restricted Stock Units granted by the issuer on September 18, 2026 and to be sold through Morgan Stanley Smith Barney LLC.

How many SOPH shares is George Cardoza planning to sell under Rule 144?

The filing states that 774 shares of SOPHiA GENETICS SA common stock are planned to be sold under Rule 144, with the shares tied to Restricted Stock Units granted on September 18, 2026.

What recent 10b5-1 sales by George Cardoza in SOPH stock are reported?

The notice reports 10b5-1 sales of SOPHiA GENETICS SA common stock: 1,592 shares sold on July 6, 2026 for $8,419.45, and 774 shares sold on June 22, 2026 for $4,163.73.

What type of securities are involved in George Cardoza’s planned SOPH sale?

The planned sale involves common stock of SOPHiA GENETICS SA, originating from Restricted Stock Units granted by the issuer on September 18, 2026, to be sold under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services.

On which market are the SOPH shares in this Form 144 listed?

The Form 144 identifies the common stock of SOPHiA GENETICS SA involved in the planned 774-share sale as listed on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 04:32 PM Accepted by SEC EDGAR 09/21/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001518734
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	GEORGE CARDOZA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	774	6339.06	85127825	09/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/18/2026	Restricted Stock Units	Issuer			774	09/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GEORGE CARDOZA La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	1592	8419.45
10b5-1 Sales for GEORGE CARDOZA La Piece 12 ch-1180 Rolle V8 00000	Common	06/22/2026	774	4163.73

144: Remarks and Signature

Remarks
Date of Notice	09/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ George Cardoza
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)